Literature DB >> 13678865

Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

Harvey D White1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 13678865     DOI： 10.1016/S0140-6736(03)14295-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  ACE inhibition in stable coronary artery disease.

Authors:  Daniel G Hackam
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

Review 2.  Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.

Authors:  Lijun Shi; Caiping Mao; Zhice Xu; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-02-17       Impact factor: 7.851

Review 3.  Perindopril: a review of its use in patients with or at risk of developing coronary artery disease.

Authors:  Monique P Curran; Paul L McCormack; Dene Simpson
Journal:  Drugs       Date:  2006       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.